Literature DB >> 11655117

Inducement in research.

Martin Wilkinson, Andrew Moore.   

Abstract

Opposition to inducement payments for research subjects is an international orthodoxy amongst writers of ethics committee guidelines. We offer an argument in favour of these payments. We also critically evaluate the best arguments we can find or devise against such payments, and except in one very limited range of circumstances, we find these unconvincing.

Keywords:  Analytical Approach; Biomedical and Behavioral Research

Mesh:

Year:  1997        PMID: 11655117     DOI: 10.1111/1467-8519.00078

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  31 in total

1.  Paying hypertension research subjects.

Authors:  David Casarett; Jason Karlawish; David A Asch
Journal:  J Gen Intern Med       Date:  2002-08       Impact factor: 5.128

2.  The influence of risk and monetary payment on the research participation decision making process.

Authors:  J P Bentley; P G Thacker
Journal:  J Med Ethics       Date:  2004-06       Impact factor: 2.903

3.  Research ethics committees and paternalism.

Authors:  S J L Edwards; S Kirchin; R Huxtable
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

4.  Strategies to minimize risks and exploitation in phase one trials on healthy subjects.

Authors:  Adil E Shamoo; David B Resnik
Journal:  Am J Bioeth       Date:  2006 May-Jun       Impact factor: 11.229

Review 5.  Towards evidence based bioethics.

Authors:  Scott D Halpern
Journal:  BMJ       Date:  2005-10-15

Review 6.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

7.  Kidney sales and the analogy with dangerous employment.

Authors:  Erik Malmqvist
Journal:  Health Care Anal       Date:  2015-06

8.  What we worry about when we worry about the ethics of clinical research.

Authors:  David Wendler
Journal:  Theor Med Bioeth       Date:  2011-06

9.  Appraising Harm in Phase I Trials: Healthy Volunteers' Accounts of Adverse Events.

Authors:  Lisa McManus; Arlene Davis; Rebecca L Forcier; Jill A Fisher
Journal:  J Law Med Ethics       Date:  2019-06       Impact factor: 1.718

10.  Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research.

Authors:  Laura B Dunn; Daniel S Kim; Ian E Fellows; Barton W Palmer
Journal:  Schizophr Bull       Date:  2008-02-14       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.